Related Experiment Video
Updated: Jan 11, 2026

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
[Cannabinoid Hyperemesis Syndrome: A Scoping Review].
Udo Bonnet1,2
1Klinik für Seelische Gesundheit, Evangelisches Krankenhaus Castrop-Rauxel, Castrop-Rauxel, Akademisches Lehrkrankenhaus der Universität Duisburg-Essen, Germany.
Cannabinoid hyperemesis syndrome (CHS), linked to chronic cannabis use, is increasingly seen in emergency departments. Abstinence is key for remission, presenting an interdisciplinary challenge for healthcare providers.
Area of Science:
- Gastroenterology
- Addiction Medicine
- Emergency Medicine
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chronic Pancreatitis II: Collaborative Care
Assessment:
Pathophysiology of Vomiting

